Inspira Technologies (IINN) Appoints Dekel Stavi to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Stocks and yen struggle as tech troubles weigh
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steady as US demand concerns balance Middle East conflict risks
- Yen hits fresh 34-year lows against dollar ahead of BOJ meeting
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market
July 26, 2021 11:04 AM EDTRA'ANANA, Israel, July 26, 2021 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW), today announced the expansion of its North American presence with the appointment of Dr. Dekel Stavi, MD, Senior Intensive Care Clinician, for the company's Medical Advisory Board. The appointment of Dr. Stavi to the company's Medical Advisory Board forms a part of Inspira's strategic future expansion into the North American market.
